Rankings / Longevity — Senolytics & Polyphenols

Senolytics (D+Q combo)

Longevity · Senolytic

Tier C+

senolyticpolyphenolanti-inflammatoryprescription
5.5 / 10
Tier C+
Ev 6.0 Bn 5.0 Sf 5.0 Ax 6.0

What this is

First-ever senolytic human trials (Justice 2019, Hickson 2019). Reduced senescent cell markers in adipose tissue; improved physical function in IPF. Epigenetic clock data mixed. Long-term safety in healthy adults unknown.

Mechanism

Dasatinib (BCR-ABL/Src inhibitor) + Quercetin (flavonoid) selectively kill senescent cells by disabling pro-survival SCAP pathways; cleared SnCs reduce SASP inflammation

Dose & route

D 100 mg + Q 1000 mg x 2-3 consecutive days, then 2-4 weeks off (intermittent "hit-and-run"); multiple cycles

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.